ResMed Inc (RMD)
243.78
+0.18
(+0.07%)
USD |
NYSE |
Nov 22, 16:00
241.59
-2.19
(-0.90%)
Pre-Market: 20:00
ResMed Cash from Investing (Quarterly): 2.146M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.146M |
| June 30, 2024 | -46.51M |
| March 31, 2024 | -33.15M |
| December 31, 2023 | -41.14M |
| September 30, 2023 | -148.98M |
| June 30, 2023 | -46.52M |
| March 31, 2023 | -28.10M |
| December 31, 2022 | -1.026B |
| September 30, 2022 | -58.81M |
| June 30, 2022 | -55.24M |
| March 31, 2022 | -49.50M |
| December 31, 2021 | -83.31M |
| September 30, 2021 | -41.87M |
| June 30, 2021 | -48.07M |
| March 31, 2021 | -58.62M |
| December 31, 2020 | -29.66M |
| September 30, 2020 | -22.11M |
| June 30, 2020 | -3.407M |
| March 31, 2020 | -99.61M |
| December 31, 2019 | -43.62M |
| September 30, 2019 | -33.22M |
| June 30, 2019 | -43.89M |
| March 31, 2019 | -225.41M |
| December 31, 2018 | -658.22M |
| September 30, 2018 | -148.19M |
| Date | Value |
|---|---|
| June 30, 2018 | -38.53M |
| March 31, 2018 | -19.62M |
| December 31, 2017 | -28.26M |
| September 30, 2017 | -15.42M |
| June 30, 2017 | -31.28M |
| March 31, 2017 | -17.92M |
| December 31, 2016 | -19.52M |
| September 30, 2016 | -13.17M |
| June 30, 2016 | -818.16M |
| March 31, 2016 | -83.73M |
| December 31, 2015 | -161.11M |
| September 30, 2015 | -62.75M |
| June 30, 2015 | -23.48M |
| March 31, 2015 | -19.00M |
| December 31, 2014 | -59.00M |
| September 30, 2014 | -41.60M |
| June 30, 2014 | -22.84M |
| March 31, 2014 | -23.20M |
| December 31, 2013 | -27.36M |
| September 30, 2013 | -21.59M |
| June 30, 2013 | -26.48M |
| March 31, 2013 | -21.00M |
| December 31, 2012 | -15.53M |
| September 30, 2012 | -14.98M |
| June 30, 2012 | -8.151M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.026B
Minimum
Dec 2022
2.146M
Maximum
Sep 2024
-98.12M
Average
-46.52M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Globus Medical Inc | -14.97M |
| Haemonetics Corp | -23.37M |
| Abbott Laboratories | -594.00M |
| Merit Medical Systems Inc | -115.67M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 325.54M |
| Cash from Financing (Quarterly) | -150.76M |
| Free Cash Flow | 1.347B |
| Free Cash Flow Per Share (Quarterly) | 2.073 |
| Free Cash Flow to Equity (Quarterly) | 335.67M |
| Free Cash Flow to Firm (Quarterly) | 307.28M |
| Free Cash Flow Yield | 3.74% |